Protocol Change to Stem Cell HIV Study

ClinicalTrials.gov Identifier:

NCT02500849

OLD:

At 9-12 months after SB-728mR-HSPC infusion, subjects who are aviremic with CD4 cell counts 500 cells/L and have 1% CCR5-modified CD4 cells within the peripheral blood detected by pentamer PCR will undergo an ATI. 

NEW:

At 9-12 months after SB-728mR-HSPC infusion, subjects who are aviremic with CD4 cell counts 600 cells/L and have 1% CCR5-modified CD4 cells within the peripheral blood detected by pentamer PCR will undergo an ATI. 

ADDITION:

- The SB-728mR-HSPC product passed all release testing

Ages Eligible for Study increased from 65 to 75

https://clinicaltrials.gov/ct2/show/NCT02500849?term=NCT02500849&rank=1